Opko Health Inc (OPK)
$4.22
0.03 (0.72%)
19:59 EST
OPK Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
2.36B
PE Ratio
-7.40
EPS
-0.57
Volume (Avg. Vol.)
10.49M
Day's Range
3.83 - 4.23
52-Week Range
1.12 - 6.47
Dividend & Yield
N/A (N/A)
OPK Stock Predictions, Articles, and Opko Health Inc News
- From InvestorPlace
- From the Web
7 Penny Stocks Close To Busting Through the $5 Mark
These seven penny stocks are most likely to push through the $5 mark having built a significant head of steam in the past year.
8 Sleeper Stocks That Could Take Off Soon
With the crazy bullishness in the market, you can’t find too many discounted plays. However, these sleeper stocks might just give your portfolio the kickstart it needs in 2021.
7 Best Penny Stocks to Buy Early Into 2021
Penny stocks are cheap for a reason, as there are obvious flaws. However, with those flows comes opportunity. Let's look at some.
10 Penny Stocks You’re Better Off Avoiding
Penny stocks by nature are risky. These 10 stocks have even higher-than-usual risks, which makes them dangerous for most investors.
Opko Stock Is a Covid-19 Testing Name Worth Betting On
Opko is generating strong revenue from testing for the coronavirus, while its HGH drug looks quite promising. As a result, OPK stock is a buy.
Buy Opko Stock For Two Ways to Play the Ongoing Pandemic
Opko is conducting a coronavirus treatment study, as well as providing Covid-19 tests. That gives OPK stock two ways to play the virus.
Corporate Insiders Pull the Trigger on These 5 Stocks
Market watchers are looking to the insiders, hoping insights from their activity can steer them towards returns.
Roche Holding News: RHHBY Stock Jumps 8% on Faster Coronavirus Test
Roche Holding (RHHBY) news for Friday includes an update on testing for the coronavirus from China with approval from the FDA.
OPKO Health News: Why OPK Health Stock Is Soaring 30% Today
OPKO Health (OPK) news for Friday concerning new testing for the coronavirus from China in New York has OPK stock soaring higher.
OPK Stock Rockets 13% Higher on Coronavirus Test Announcement
Opko Health (OPK) is seeing OPK stock head higher on Friday following an announcement concerning a test for the coronavirus from China.
3 Big Stock Charts for Tuesday: Apple, Scana and Procter & Gamble
Stock charts of AAPL, PG and SCG have earned a closer look from traders as today's session gets started.
7 Biotech Stocks to Buy Now
Biotech companies are recovering nicely this year. With a quarter left to go, the upside potential is high for those biotech stocks that dipped recently.
3 Big Stock Charts for Monday: PG&E, Oracle and Weyerhaeuser
The stock charts of PCG, WY and ORCL are run through the technical trading wringer. Here's the next likely move for all three.
OPKO Stock Had a Great Q2 and the Future Looks Even Better
With shares nearly double where they were in May, OPKO Health, Inc. (NASDAQ:OPK) needed a strong second-quarter earnings report to justify the gains in OPKO....
Friday’s Vital Data: Nvidia Corporation (NVDA), Netflix, Inc. (NFLX) and Opko Health Inc. (OPK)
Nvidia (NVDA) options jump on Bosch deal, Bernstein believes in Netflix (NFLX) and Opko Health (OPK) initiated at Guggenheim.
3 Stocks to Buy for Under $10 With 25%-Plus Upside
Analysts see Rite Aid (RAD), Chesapeake Energy (CHK) and Opko Health (OPK) as three cheap stocks to buy with major near-term upside.
Thursday’s Vital Data: Facebook Inc (FB), Opko Health Inc. (OPK) and Nvidia Corporation (NVDA)
Facebook (FB) eyes streaming video, Opko Health (OPK) options spike amid kidney drug release and Nvidia (NVDA) upgraded at Evercore ISI.
24 Biotechnology Stocks to Sell Now
This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
32 Biotechnology Stocks to Sell Now
This week, the overall grades of 32 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
25 Biotechnology Stocks to Buy Now
25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
Buy